Cigarette smoking and chromosome 9 alterations in bladder cancer

Epidemiological studies suggest that bladder cancer may be caused by carcinogens in tobacco and certain occupational exposures. Molecular studies have shown that chromosome 9 alterations and TP53 mutations are the most frequent events in bladder cancer. To date, the relationships between epidemiolog...

Full description

Saved in:

Bibliographic Details
Published in:	Cancer epidemiology, biomarkers & prevention Vol. 6; no. 5; p. 321
Main Authors:	Zhang, Z F, Shu, X M, Cordon-Cardo, C, Orlow, I, Lu, M L, Millon, T V, Cao, P Q, Connolly-Jenks, C, Dalbagni, G, Lianes, P, Lacombe, L, Reuter, V E, Scher, H
Format:	Journal Article
Language:	English
Published:	United States American Association for Cancer Research 01-05-1997
Subjects:	Chromosome Aberrations - genetics Chromosome Mapping Chromosomes, Human, Pair 9 Cocarcinogenesis Confidence Intervals Gene Expression Regulation, Neoplastic - physiology Genes, Tumor Suppressor - genetics Humans Occupational Exposure - adverse effects Odds Ratio Polymerase Chain Reaction Polymorphism, Restriction Fragment Length Smoking - adverse effects Smoking - epidemiology Tumor Suppressor Protein p53 - genetics Urinary Bladder - pathology Urinary Bladder Neoplasms - epidemiology Urinary Bladder Neoplasms - genetics
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Epidemiological studies suggest that bladder cancer may be caused by carcinogens in tobacco and certain occupational exposures. Molecular studies have shown that chromosome 9 alterations and TP53 mutations are the most frequent events in bladder cancer. To date, the relationships between epidemiological risk factors and genetic alterations have not been fully explored in bladder cancer. The purpose of this study was to explore the association between smoking and chromosome 9 aberrations in bladder cancer cases. Seventy-three patients with bladder cancer at Memorial Sloan-Kettering Cancer Center were evaluated for smoking history, occupational history, and chromosome 9 alterations. The epidemiological data were abstracted from medical charts. Patients' tumor tissues were analyzed using RFLP and microsatellite polymorphism assays for detection of chromosome 9 alterations. Elevated odds ratios (ORs) were found for chromosome 9 alterations in smokers compared to those in nonsmokers (OR = 4.2; 95% confidence interval, 1.02-17.0) after controlling for age, sex, race, occupational history, and stage of disease. The ORs were 3.6 for those smoking < or = 20 cigarettes per day and 5.8 for those smoking > 20 cigarettes per day. No association was found between occupational history and chromosome 9 alterations. This study supplies evidence suggestive of the link between smoking and chromosome 9 alterations in the etiology of bladder cancer and indicates that potential tumor suppressor genes on chromosome 9 may be involved in smoking-related bladder carcinogenesis.
ISSN:	1055-9965 1538-7755